Impact of Bean Polyphenols and Phytic Acid on Iron Absorption
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Recently isolated low PA varieties (lpa) in wheat, rice, maize, barley and beans might have the potential to alleviate iron bioavailability problems associated with PA. These plants have normal phosphate levels, but reduced PA phosphate due to various modifications of the biosynthetic pathway of PA. So far lpa crops are in an early stage of development, most of them exhibiting reduced yield and seed germination. However, the lpa bean isolated by Campion and co-workers 2009 by chemical mutagenesis exhibited only 10 % of the native bean PA concentration without any defects in terms of growth and yield.
Crossing the lpa variety with bean varieties low in PP and high in iron might lead to the development of a variety which has the potential to improve the iron status of bean consuming populations.
The following study will evaluate the relative impact of PA and PP on iron absorption from beans by comparing iron absorption from four different bean varieties. Iron absorption from a bean with normal PA concentration and high PP concentration will be compared to iron absorption from a bean with normal PA and low PP concentration as well as to two lpa varieties, one with high and one with low PP concentration.
| Condition | Intervention |
|---|---|
|
Blood Iron Isotope Enrichment |
Other: 586/8x87 white Other: 586/8x87 brown Other: BAT 881 Other: 586/8 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Bio-availability Study Intervention Model: Crossover Assignment Masking: Single Blind (Subject) Primary Purpose: Basic Science |
| Official Title: | A Stable Iron Isotope Study to Investigate the Impact of Phytic Acid and Polyphenols on Iron Absorption From Beans in Humans |
- Shift in iron isotopic composition in blood after consumption of different bean varieties [ Time Frame: 1 month ] [ Designated as safety issue: No ]
| Enrollment: | 20 |
| Study Start Date: | December 2011 |
| Study Completion Date: | January 2012 |
| Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: lpa with high polyphenol |
Other: 586/8x87 brown
2 x 50 g
|
| Experimental: lpa with low polyphenol |
Other: 586/8x87 white
2 x 50 g
|
| Experimental: control bean with low polyphenol |
Other: 586/8
2 x 50 g
|
| Experimental: control bean with high polyphenol |
Other: BAT 881
2 x 50 g
|
Eligibility| Ages Eligible for Study: | 18 Years to 40 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Non-pregnant, non-lactating women
- Between 18 and 40 years
- Below 65kg
Exclusion Criteria:
- Metabolic, chronic and gastro-intestinal disease
- Long-term medication
- Blood donation within 6 month before the study
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Prof. Michael B. Zimmermann, Prof, Swiss Federal Institute of Technology |
| ClinicalTrials.gov Identifier: | NCT01472484 History of Changes |
| Other Study ID Numbers: | lpa_586/8X87 |
| Study First Received: | November 9, 2011 |
| Last Updated: | June 18, 2012 |
| Health Authority: | Switzerland: Ethikkommission |
Keywords provided by Swiss Federal Institute of Technology:
|
beans lpa mutant polyphenols phytic acid stable iron isotopes |
ClinicalTrials.gov processed this record on May 21, 2013